Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blockchain watchdogs take on hospital fraud in new trial

NCT ID NCT07217730

Knowledge-focused Sponsor: Truway Health, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new protocol to fight fraud and kickbacks in U.S. healthcare facilities. It uses a team of validators, smart contracts, and public dashboards to monitor billing and supply chains. About 100 facilities with past irregularities will be enrolled and tracked for 12 months. The goal is to see if this system can reduce fraud and improve transparency.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Validator-governed reform protocol using smart contracts, NFT fiscal declarations, and DAO voting
What this could lead to
If successful, this could provide a new way to detect and prevent healthcare fraud, improving trust and accountability in medical facilities.
What could go wrong
This is an early-stage observational study with only 100 facilities, and the approach relies on complex technology that may not be widely adopted or effective in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2034

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of U.S. healthcare facilities identified through coalition-backed validator affidavits and whistleblower declarations. These facilities exhibit patterns of fraud, kickback schemes, and supply chain vulnerabilities. The population is monitored prospectively via smart contract triggers, DAO voting, and public dashboard metrics.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Facility has documented billing, compliance, or procurement irregularities. Facility participates in coalition validator onboarding and SHA-256 protocol enrollment. Facility provides access to billing, procurement, and whistleblower-anchored datasets for auditing. Exclusion Criteria: Facility refuses validator onboarding or coalition integration. Facility lacks traceable procurement or compliance records. Facility has no whistleblower declaration or validation artifact. Facility operates outside U.S. jurisdiction or coalition-recognized governance zones.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Governance failures are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Governance failures Healthcare fraud schemes Kickback networks Public transparency & auditability Regulatory escalation pathways Supply chain vulnerabilities Validator oversight & dao governance Whistleblower activation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.